US Patent Issued to SHANGHAI GENBASE BIOTECHNOLOGY on May 19 for "Anti-CLDN18.2 antibody and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,626, issued on May 19, was assigned to SHANGHAI GENBASE BIOTECHNOLOGY Co. LTD. (Shanghai).

"Anti-CLDN18.2 antibody and uses thereof" was invented by Liang Du (Shanghai), Hongyan Zhang (Shanghai), Wen Ling (Shanghai) and Jijun Yuan (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an anti-CLDN18.2 antibody or antigen-binding fragment thereof, a nucleic acid molecule encoding the same, an immunoconjugate, bispecific molecule, chimeric antigen receptor and pharmaceutical composition comprising the same. The antibody or antigen-binding fragment thereof is used for preventing and/or treating a tumor."

The patent was filed on Oct. 22, ...